versión imprimible
 
 

Wet AMD and DME Drug Development Summit | Virtual Event | April 13-15, 2021

Evvnt Promotion / evvnt
-
13.04.2021 - 15.04.2021  Online
Time: 08:00 - 15:45
 
Temas de la conferencia
The Wet AMD and DME Drug Development Summit comes at a critical juncture, as the research community progresses novel drug candidates targeting angiogenesis-driven disease, and a pandemic further exposes the treatment limitations for a global aging population.

The treatment landscape for Wet Age-Related Macular Degeneration (wet AMD) and Diabetic Macular Edema (DME) has dramatically changed since the first anti-VEGF therapies were approved for ocular neovascularization.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/722199-2?pid=4832

Speakers: Casey Kopczynski, Chief Scientific Officer, Aerie Pharmaceuticals, Kevin Peters, Chief Scientific and Medical Officer and Senior Vice President, Aerpio Therapeutics and more.
 

Información e inscripción:

https://go.evvnt.com/722199-0?pid=4832
Ms. Stephanie Nketia
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 1499.0 - USD 3097.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Center of ExcellenceSwiss Tropical and Public Health InstituteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Hilfswerk AustrianewTreeÄrztekammer für WienAnästhesie in Entwicklungsländern e. V.